Fisher & Paykel Healthcare Corporation Limited Ratios | P/E, ROE & Valuation

On the Key Ratios page for Fisher & Paykel Healthcare Corporation Limited (FPH), the latest P/E of 49.3 frames valuation, while ROE 22.84% and ROIC 20.72% indicates profitability and capital efficiency. Together with the current ratio of 2.31 and debt-to-equity 0.07, these signals help you judge whether valuation is supported by fundamentals across the historical rows.

Financial Performance Ratios

FPH Historical Per Share Metrics

10 years
Metric (FY)TTM202520242023202220212020201920182017
Revenue per Share$3.99$2.19$3.02$2.75$2.85$3.39$2.22$1.95$1.79$1.67
Net Income per Share$0.80$0.64$0.23$0.43$0.65$0.91$0.50$0.38$0.35$0.33
Operating Cash Flow per Share$1.13$0.94$0.74$0.41$0.56$1.09$0.56$0.46$0.43$0.34
Free Cash Flow per Share$0.84$0.76$0.16$0.05$0.27$0.77$0.26$0.22$0.29$0.22
Cash per Share$0.79$0.45$0.14$0.21$0.50$0.66$0.25$0.25$0.23$0.14
Book Value per Share$3.60$3.23$3.02$3.03$2.91$2.65$1.70$1.59$1.34$1.17
Tangible Book Value per Share$3.48$3.09$2.87$2.88$2.76$2.51$1.57$1.49$1.25$1.09
Interest Debt per Share$0.27$0.28$0.36$0.26$0.19$0.21$0.24$0.16$0.15$0.11
CAPEX per Share$0.29$0.18$0.58$0.37$0.29$0.32$0.30$0.24$0.15$0.12

FPH Historical Valuation Ratios

10 years
Metric (FY)TTM202520242023202220212020201920182017
Price to Earnings (P/E)49.2752.07114.8661.5637.2735.1660.7239.135.1227.34
Price to Book (P/B)10.9410.398.668.798.3612.1217.919.339.37.61
Price to Sales (P/S)9.915.348.669.78.559.4613.77.636.925.32
Enterprise Value to EBITDA27.9629.8541.6535.5823.2422.8340.2224.3421.2816.45
EV to Sales9.7615.258.729.718.569.4713.757.666.975.32
EV to Operating Cash Flow34.4335.635.764.7943.3629.5154.4932.4428.7926.16
EV to Free Cash Flow46.5743.82169.29573.6991.0241.88116.2168.4743.3540.63
Enterprise Value$22.84B$19.53B$15.34B$15.43B$14.06B$18.45B$17.51B$8.56B$7.13B$5.04B

FPH Historical Profitability Ratios

10 years
Metric (FY)TTM202520242023202220212020201920182017
Return on Equity (ROE)22.84%19.95%7.54%14.28%22.44%34.47%29.50%23.86%26.50%27.85%
Return on Invested Capital (ROIC)20.72%-13.01%7.18%13.19%20.91%31.53%24.34%24.30%27.16%28.81%
Return on Tangible Assets16.85%15.28%6.05%11.81%18.66%26.28%21.11%19.03%20.70%22.10%
Earnings Yield2.02%1.92%0.87%1.62%2.68%2.84%1.65%2.56%2.85%3.66%
Free Cash Flow Yield2.12%2.27%0.59%0.17%1.10%2.39%0.86%1.47%2.32%2.46%
Dividend Yield1.55%1.00%0.96%1.27%1.60%0.98%0.84%1.40%1.45%1.93%

FPH Historical Liquidity & Financial Strength

10 years
Metric (FY)TTM202520242023202220212020201920182017
Current Ratio2.311.871.832.672.922.151.552.472.382.4
Interest Coverage64.76-33.4213.9849.96103.9144.649674.8390.6186.94
Income Quality1.4203.240.950.861.191.121.211.30
Debt to Equity0.070.080.110.080.060.080.140.090.110.09
Debt to Assets5.12%6.01%8.29%6.61%4.95%5.71%9.49%7.15%8.04%6.95%
Net Debt to EBITDA-0.39-0.170.290.060.020.030.160.110.150

FPH Historical Efficiency Ratios

10 years
Metric (FY)TTM202520242023202220212020201920182017
Receivables Turnover6.824.26.67.279.428.765.727.077.017.31
Payables Turnover2.7914.1821.5614.9511.6912.86.176.710.7211.29
Inventory Turnover2.562.192.181.761.752.682.922.712.792.45
Days Sales Outstanding53.4986.8455.2750.238.7641.6963.8351.6152.0949.96
Days Payables Outstanding130.6725.7416.9324.4231.2228.5259.1154.4534.0632.32
Days of Inventory on Hand142.51166.86167.45207.74208.26136.12124.96134.48130.61148.79

FPH Historical Market Metrics

10 years
Metric (FY)TTM202520242023202220212020201920182017
Enterprise Value to EBITDA27.9629.8541.6535.5823.2422.8340.2224.3421.2816.45
Market Cap$23.15B$19.64B$15.23B$15.41B$14.05B$18.43B$17.44B$8.52B$7.08B$5.04B
Enterprise Value$22.84B$19.53B$15.34B$15.43B$14.06B$18.45B$17.51B$8.56B$7.13B$5.04B
Dividend Yield1.55%1.00%0.96%1.27%1.60%0.98%0.84%1.40%1.45%1.93%
Payout Ratio53.85%51.94%109.73%78.19%59.67%34.59%50.96%54.78%50.81%52.83%

Frequently Asked Questions

How does Fisher & Paykel Healthcare Corporation Limited’s P/E ratio compare with its history?

On this page, FPH's current P/E is 49.3, compared with a multi-year average around 51.2. When the current P/E sits near its historical average, the multiple is close to that range. Look at trend direction in profitability and cash-flow rows, plus liquidity and leverage, rather than treating the P/E in isolation.

What is Fisher & Paykel Healthcare Corporation Limited market cap?

Market cap is the market value of a company's equity and is commonly calculated as share price multiplied by shares outstanding. The latest market cap shown in the table is $23.15B. Pair market cap with valuation multiples (P/E, P/B, P/S) so you can evaluate whether size also corresponds with "quality" and profitability. For a wider view across stocks, you can also use the stock screener.

How does Fisher & Paykel Healthcare Corporation Limited’s P/E compare with its industry?

There is no P/E Tickerplace rates as good. Compare the P/E on this page with Fisher & Paykel Healthcare Corporation Limited's own historical range (in the table) and with peers via the Screener and Compare tools. A higher or lower multiple versus peers is a calculated gap, not a recommendation.

How does Fisher & Paykel Healthcare Corporation Limited compare to its competitors in key financial ratios?

The fastest way to compare Fisher & Paykel Healthcare Corporation Limited with competitors is to use the built-in "Peers Comparison" section on this page and the Compare tool. Focus on a small set of ratios that work together: P/E for valuation, ROE/ROIC for profitability and capital efficiency, current ratio and interest coverage for liquidity and solvency, and debt-to-equity for leverage risk. When you see Fisher & Paykel Healthcare Corporation Limited outperform peers on profitability while keeping valuation and leverage reasonable, it often signals stronger fundamentals.

What do Fisher & Paykel Healthcare Corporation Limited's liquidity and leverage ratios show?

Liquidity and leverage figures on this page are published ratios, not a verdict that Fisher & Paykel Healthcare Corporation Limited is financially strong. Current ratio is about 2.31, which is above 1.0 and can indicate more comfortable short-term liquidity. Interest coverage is about 64.76, implying a stronger ability to cover interest expenses. Debt-to-equity is about 0.07, suggesting leverage is more moderate relative to a high-debt profile. Pair them with ROE/ROIC and cash-flow rows in the table. Tickerplace does not rate the company as a good or poor investment.

What do Fisher & Paykel Healthcare Corporation Limited's financial ratios say about its future growth?

Ratios are a way to see what the business is likely to sustain. Look for upward trends in profitability metrics (ROE and ROIC), improving earnings/cash-flow backed measures, and stable or strengthening liquidity. If Fisher & Paykel Healthcare Corporation Limited is sustaining strong returns (for example ROE at 22.84% and ROIC at 20.72%) while debt levels and interest coverage remain manageable, growth expectations may be more credible. If valuation multiples expand while returns weaken, the market may be pricing optimistic growth ahead of results.